SICANDRA MEDICAL

Active

Private limited companyfounded 1980active for 46 yearsMargrietendreef(P.E.) 28, 7850 Enghien, BelgiumKBO/BCE: BE 0420.040.682

Summary

SICANDRA MEDICAL has been active since 1980 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €339,196 and a net result of €67,990. Equity is growing by about 22% per year across the filed financial years. Its solvency ranks better than 76% of 20,643 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

SICANDRA MEDICALActiveChecked score 96/100

Risk analysis Report Compare

Activity

General medical practice

NACE 86210

3rd oldest company in Enghien, Health and social work sector6 sites

Size

≈ €200,000turnover 2025, estimated

Equity: €339,196
Profit: €67,990

Turnover estimated from the gross margin

Financial health

96 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Structure

2025 accounts filed 24 days late8 deeds in the Belgian Official Gazette

Why 96raises riskLast filed accounts filed 24 days late; 2 of the last 3 latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 6.31, cash €188,869Equity €339,196 (84.9% of total assets)Show the evidence

Checked score

Score 2025

96 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 66% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 100=

equity 84.9% of total assets

Liquidity 97-3

short-term debt 15.1% · cash 47.3%

Profitability 90-5

return on assets 17.0%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,138 companies, NACE 86, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026highest value 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €30,000 on 30-day terms is acceptable

Liquidity ample (current ratio 6.31, compared with 15.09 in 2024, above the usual 1.5; short-term debt: 15.1% and cash: 47.3% of total assets), and 15.1% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 85% on liquidity, 45% on profitability and 54% on growth.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises risk

Sector: Human health activities (NACE 86)

KBO

Liquidity: current ratio 6.31, cash €188,869

NBB · annual accounts

Last filed accounts filed 24 days late; 2 of the last 3 late

NBB · filings

Equity €339,196 (84.9% of total assets)

NBB · annual accounts

2025 accounts filed 24 days late

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.

NBB · 10 filings

Deviation from the deadline

2025

24 days late

2024

41 days late

2023

41 days late

2022

48 days early

2021

29 days late

2020

4 days late

2019

30 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 9 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 August (4 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

29-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

24-08-2026 Annual accounts filedfinancial year 2025 · micro…
10-09-2025 Annual accounts filedfinancial year 2024 · micro…
31-12-2024 Highest result from 2018 to 2025net €68,995 ▲83.2%

Key points

Positive: 3rd oldest company in Enghien, Health and social work sectorin the Checked rankings No. 3 View
Positive: 8 profitable years in a rowprofit 2025: €67,990 8 years View
Active since 1980founded 11-01-1980 46 years View

By topic

Financials

Financial year: 2025
Total assets: €399,688
Profit: €67,990
Solvency: 84.9%

Turnover▲ 0.1%

Net result

20182019

Go to Financials

Timeline

Events: 50
Since: 1981
Next accounts: by 31-07-2027

10-09-2024Annual accounts filed
13-06-2023Annual accounts filed
31-12-2022Equity above €200,000

Go to Timeline

Company details

Sites: 6

Legal form: Private limited company
Activity: General medical practiceNACE 86210
Founded: 11-01-1980
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Key facts about SICANDRA MEDICAL

What is the company number of SICANDRA MEDICAL?: 0420.040.682. In Belgium the VAT number is the company number with BE in front: BE 0420.040.682.
Where is SICANDRA MEDICAL based?: The registered office is at Margrietendreef(P.E.) 28, 7850 Enghien.Company details
What does SICANDRA MEDICAL do?: According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of SICANDRA MEDICAL?: Private limited company (BV).
When was SICANDRA MEDICAL founded?: On 11-01-1980.
Is SICANDRA MEDICAL still active?: Yes, SICANDRA MEDICAL is an active enterprise in the KBO register.
What is the turnover of SICANDRA MEDICAL?: €123,395 in financial year 2019, according to the filed annual accounts.Financials
Is SICANDRA MEDICAL profitable?: In financial year 2025, SICANDRA MEDICAL made a profit of €67,990.
Where can I find the annual accounts of SICANDRA MEDICAL?: SICANDRA MEDICAL filed 44 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SICANDRA MEDICAL due?: By 31-07-2027, for financial year 2026.Timeline